Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 5NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 3Gliosarcoma 2Glioblastoma 2Central Nervous System Neoplasms 2Breast Neoplasms, Male 2Waldenstrom Macroglobulinemia 1Somatostatinoma 1Sarcoma 1Rhabdoid Tumor 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Osteosarcoma 1Mesothelioma, Malignant 1Meningioma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Kidney Neoplasms 1Insulinoma 1Immunoblastic Lymphadenopathy 1Glucagonoma 1

Interventions

ribociclib 1Specimen Handling 1Panobinostat 1Fluid Therapy 1Everolimus 1CBLC137 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Diffuse Intrinsic Pontine Glioma × Everolimus × Clear all
NCT03387020 2021-08-27

Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors

Pediatric Brain Tumor Consortium

Phase 1 Completed
22 enrolled 16 charts
CNS

Familial ependymoma, Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡